Diasorin Gets FDA 510(k) Clearance for New Multiplexing Platform
Diasorin received FDA 510(k) clearance for its new Liaison Plex platform and first panel of tests, the Liaison Plex Respiratory Flex Assay.
Read MorePosted by Andy Lundin | Mar 4, 2024 | Diagnostic Technologies, Respiratory Disease |
Diasorin received FDA 510(k) clearance for its new Liaison Plex platform and first panel of tests, the Liaison Plex Respiratory Flex Assay.
Read MorePosted by Andy Lundin | Mar 1, 2024 | Prostate |
AI has helped scientists reveal a new form of aggressive prostate cancer which could revolutionize how the disease is diagnosed in the future.
Read MorePosted by Chris Wolski | Feb 28, 2024 | Lab Management |
Workflow analysis, supported by a partner, is key to helping labs identify strategies and implement changes that boost their efficiency.
Read MorePosted by Andy Lundin | Feb 23, 2024 | Company News |
To ensure business continuity and effective leadership, the Board formed the Office of the Chief Executive Officer, led by Michael Iskra.
Read MorePosted by Andy Lundin | Feb 23, 2024 | Immunoassay Reagents & test Kits |
Werfen received CE mark for its Aptiva Antiphospholipid Syndrome IgG and IgM reagents under the EU’s IVDR.
Read More